SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.14%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$143M
AUM Growth
+$143M
(-57%)
Cap. Flow
-$196M
Cap. Flow
% of AUM
-136.94%
Top 10 Holdings %
Top 10 Hldgs %
34.85%
Holding
254
New
32
Increased
29
Reduced
57
Closed
61
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
$4.65M |
| 2 |
BIOA
BioAmber Inc.
BIOA
|
$3.39M |
| 3 |
OTIC
Otonomy, Inc.
OTIC
|
$3.29M |
| 4 |
BLRX
BioLineRX
BLRX
|
$3.02M |
| 5 |
United Therapeutics
UTHR
|
$2.35M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$59.7M |
| 2 |
Sarepta Therapeutics
SRPT
|
$55.3M |
| 3 |
Amgen
AMGN
|
$35.4M |
| 4 |
Eli Lilly
LLY
|
$15.7M |
| 5 |
Biogen
BIIB
|
$5.67M |
Sector Composition
| 1 | Healthcare | 83.28% |
| 2 | Materials | 3.26% |
| 3 | Consumer Staples | 0.47% |
| 4 | Consumer Discretionary | 0.4% |
| 5 | Energy | 0% |
